Therefore, given the present finding that the early-phase administration of A-770041, but not the late-phase, ameliorated BLM-induced lung fibrosis, the therapeutic effect of Lck inhibition in Tregs in the early stage of lung fibrosis may also be due in part to changes in the Treg function. This evidence concerns the gene LCK and pulmonary fibrosis.